COLLEGIUM PHARMACEUTICAL INCCOLL
ASignal's systematic analysis rates COLL as Neutral.
Reflects the latest available analysis · analyzed Sep 22, 2026
The case on COLL
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Gross margin of 89.45% indicates strong pricing power
- Forward P/E of 3.48x suggests potential undervaluation relative to growth
- Free cash flow of $324.04M supports financial flexibility
- Return on equity of 17.61% reflects solid capital efficiency
- Price near Bollinger Lower Band (20.47) indicating potential reversal support
- Debt-to-equity ratio of 3.90x raises financial risk concerns
- Quick ratio of 0.70x indicates potential liquidity pressure
- Negative price momentum (-0.014) and MACD below signal line
- No Reddit mentions, suggesting lack of retail interest or visibility
- SMA50 (29.15) significantly above current price, indicating long-term downtrend
See the full verdict on COLL
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes COLL
Most investors never get a second opinion, let alone several. ASignal runs COLL past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.